| Steensma DP
New ASH/ASCO guidelines on the use of erythropoiesis-stimulating agents: a chorale amid cacophony. [Journal Article]
J Support Oncol 2007 Nov-Dec; 5(10):471-3.
Full Citation | Find Related Articles |
| Sipkoff M
Rebates for anti-anemia drugs draw response from FDA, CMS. [Journal Article]
Manag Care 2007 Jun; 16(6):17-8.
Full Citation | Find Related Articles |
| Steinbrook R
Erythropoietin, the FDA, and oncology. [Journal Article]
N Engl J Med 2007 Jun 14; 356(24):2448-51.
Full Citation | Publisher Full Text | Find Related Articles |
| Schwartzberg L, Shiffman R, Tomita D, et al.
A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia. [Journal Article, Multicenter Study]
Clin Ther 2003 Nov; 25(11):2781-96.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Lappin TR, Maxwell AP, Johnston PG
Warning flags for erythropoiesis-stimulating agents and cancer-associated anemia. [Journal Article]
Oncologist 2007 Apr; 12(4):362-5.
Full Citation | Publisher Full Text | Find Related Articles |
| Nowrousian MR, Dunst J, Vaupel P
Erythropoiesis-Stimulating Agents: Favorable Safety Profile When Used as Indicated. [JOURNAL ARTICLE]
Strahlenther Onkol 2008 Mar; 184(3):121-136.
Abstract | Full Citation |
| Steensma DP, Loprinzi CL
Epoetin alfa and darbepoetin alfa go head to head. [Comment, Editorial]
J Clin Oncol 2006 May 20; 24(15):2233-6.
Full Citation | Publisher Full Text | Find Related Articles |
| Longfield V, Gebhart B, Hayward L
Development of a strategy to successfully convert an ambulatory infusion center from epoetin alfa to darbepoetin alfa. [Journal Article]
J Support Oncol 2005 Nov-Dec; 3(6 Suppl 4):8-9.
Full Citation | Find Related Articles |
| Zitella L
Erythropoietin-stimulating agents: new data yield new insights. [Journal Article]
Oncology (Williston Park) 2007 Oct; 21(11 Suppl Nurse Ed):36-8.
Full Citation | Find Related Articles |
  |
New! 